Grifols Sa Adr Stock Today

GRFS Stock  USD 6.68  0.03  0.45%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Less than 9

 
100  
 
Zero
Low
Grifols SA is selling for under 6.68 as of the 29th of March 2024; that is 0.45 percent up since the beginning of the trading day. The stock's lowest day price was 6.5. Grifols SA has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Grifols SA ADR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of April 2023 and ending today, the 29th of March 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
17th of May 2006
Category
Healthcare
Classification
Health Care
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company was founded in 1940 and is headquartered in Barcelona, Spain. Grifols SA operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. The company has 679.09 M outstanding shares of which 8.19 M shares are currently shorted by private and institutional investors with about 2.39 trading days to cover. More on Grifols SA ADR

Moving together with Grifols Stock

  0.75MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
  0.8KA Kineta Inc Financial Report 9th of May 2024 PairCorr

Moving against Grifols Stock

  0.8MDWD Mediwound Downward RallyPairCorr
  0.63CLVRW Clever Leaves HoldingsPairCorr
  0.54YS YS Biopharma Report 22nd of April 2024 PairCorr
  0.51EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.5MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.48MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Grifols Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Grifols SA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Grifols SA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO of Laboratorios Grifols SAAlbert Roura
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Drug Manufacturers—General, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering Grifols SA report their recommendations after researching Grifols SA's financial statements, talking to executives and customers, or listening in on Grifols SA's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Grifols SA ADR. The Grifols consensus assessment is calculated by taking the average forecast from all of the analysts covering Grifols SA.
Financial Strength
Based on the key measurements obtained from Grifols SA's financial statements, Grifols SA ADR is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April. Financial strength of Grifols SA ADR is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.00260.0028
Notably Down
Slightly volatile
Asset Turnover0.50.3073
Way Up
Slightly volatile
Gross Profit Margin0.620.3524
Way Up
Slightly volatile
Net Debt10.1 B9.6 B
Sufficiently Up
Slightly volatile
Total Current Liabilities2.4 B2.3 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total11.7 B11.2 B
Sufficiently Up
Slightly volatile
Total Assets22.5 B21.5 B
Sufficiently Up
Slightly volatile
Total Current Assets6.8 B6.5 B
Sufficiently Up
Slightly volatile
Grifols SA's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Grifols SA's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Grifols SA's financial leverage. It provides some insight into what part of Grifols SA's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Grifols SA's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Grifols SA deploys its capital and how much of that capital is borrowed.
Liquidity
Grifols SA cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 10.12 B in liabilities with Debt to Equity (D/E) ratio of 1.14, which is about average as compared to similar companies. Grifols SA ADR has a current ratio of 2.63, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Grifols SA until it has trouble settling it off, either with new capital or with free cash flow. So, Grifols SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Grifols SA ADR sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Grifols to invest in growth at high rates of return. When we think about Grifols SA's use of debt, we should always consider it together with cash and equity.

Other Non Cash Items

75.61 Million
Grifols SA ADR (GRFS) is traded on NASDAQ Exchange in USA. It is located in Avinguda de la Generalitat, 152, Barcelona, Spain, 08174 and employs 23,744 people. Grifols SA is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.42 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Grifols SA's market, we take the total number of its shares issued and multiply it by Grifols SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Grifols SA ADR conducts business under Biotechnology sector and is part of Health Care industry. The entity has 679.09 M outstanding shares of which 8.19 M shares are currently shorted by private and institutional investors with about 2.39 trading days to cover. Grifols SA ADR currently holds about 549.09 M in cash with 208.28 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.4.
Check Grifols SA Probability Of Bankruptcy
Ownership Allocation
Grifols SA secures a total of 679.09 Million outstanding shares. 30% of Grifols SA ADR outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Grifols Ownership Details

Grifols Stock Price Odds Analysis

Attributed to a normal probability distribution, the odds of Grifols SA jumping above the current price in 90 days from now is about 80.03%. The Grifols SA ADR probability density function shows the probability of Grifols SA stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.1485. This usually indicates Grifols SA ADR market returns are related to returns on the market. As the market goes up or down, Grifols SA is expected to follow. Additionally, grifols SA ADR has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 6.68HorizonTargetOdds Above 6.68
19.90%90 days
 6.68 
80.03%
Based on a normal probability distribution, the odds of Grifols SA to move above the current price in 90 days from now is about 80.03 (This Grifols SA ADR probability density function shows the probability of Grifols Stock to fall within a particular range of prices over 90 days) .

Grifols Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Grifols SA that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Grifols SA's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Grifols SA's value.
InstituionRecorded OnShares
Morgan Stanley - Brokerage Accounts2023-12-31
M
Harris Associates L.p.2023-12-31
2.8 M
Norges Bank2023-12-31
2.3 M
Blackrock Inc2023-12-31
2.1 M
New York State Common Retirement Fund2023-12-31
2.1 M
Sei Investments Co2023-12-31
M
Jpmorgan Chase & Co2023-12-31
1.9 M
Fidelity International Ltd2023-12-31
1.8 M
Hhg Plc2023-12-31
1.8 M
Capital World Investors2023-12-31
19.8 M
Millennium Management Llc2023-12-31
15.7 M
View Grifols SA Diagnostics

Grifols SA Historical Income Statement

Grifols SA ADR Income Statement is one of the three primary financial statements used for reporting Grifols's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Grifols SA ADR revenue and expense. Grifols SA Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Grifols SA's Depreciation And Amortization is comparatively stable compared to the past year. Interest Expense is likely to gain to about 665.4 M in 2024, whereas Total Revenue is likely to drop slightly above 3.5 B in 2024. View More Fundamentals

Grifols Stock Against Markets

Picking the right benchmark for Grifols SA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Grifols SA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Grifols SA is critical whether you are bullish or bearish towards Grifols SA ADR at a given time. Please also check how Grifols SA's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Grifols SA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Analyzer Now

   

Portfolio Analyzer

Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
All  Next Launch Module

Grifols SA Corporate Directors

Grifols SA corporate directors refer to members of a Grifols SA board of directors. The board of directors generally takes responsibility for the Grifols SA's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Grifols SA's board members must vote for the resolution. The Grifols SA board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Antonio ParesDirector of Planning and ControlProfile
Anna LluchIndependent DirectorProfile
Jose GrasDirector, Representative of Thorthol Holdings BVProfile
Edgar JannottaIndependent DirectorProfile

How to buy Grifols Stock?

Before investing in Grifols SA, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Grifols SA. To buy Grifols SA stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Grifols SA. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Grifols SA stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Grifols SA ADR stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Grifols SA ADR stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Grifols SA ADR, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Grifols Stock please use our How to Invest in Grifols SA guide.

Already Invested in Grifols SA ADR?

The danger of trading Grifols SA ADR is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Grifols SA is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Grifols SA. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Grifols SA ADR is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Grifols SA ADR is a strong investment it is important to analyze Grifols SA's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Grifols SA's future performance. For an informed investment choice regarding Grifols Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Grifols SA ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census.
Note that the Grifols SA ADR information on this page should be used as a complementary analysis to other Grifols SA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Grifols Stock analysis

When running Grifols SA's price analysis, check to measure Grifols SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols SA is operating at the current time. Most of Grifols SA's value examination focuses on studying past and present price action to predict the probability of Grifols SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grifols SA's price. Additionally, you may evaluate how the addition of Grifols SA to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Is Grifols SA's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Grifols SA. If investors know Grifols will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Grifols SA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.787
Earnings Share
0.1
Revenue Per Share
4.849
Quarterly Revenue Growth
0.033
Return On Assets
0.0214
The market value of Grifols SA ADR is measured differently than its book value, which is the value of Grifols that is recorded on the company's balance sheet. Investors also form their own opinion of Grifols SA's value that differs from its market value or its book value, called intrinsic value, which is Grifols SA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Grifols SA's market value can be influenced by many factors that don't directly affect Grifols SA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Grifols SA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Grifols SA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Grifols SA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.